TY - JOUR T1 - Diagnostic yield, safety and utilisation of EBUS-TBNA under conscious sedation JF - European Respiratory Journal JO - Eur Respir J VL - 42 IS - Suppl 57 SP - P5083 AU - Usman Maqsood AU - Selva Selvaraj AU - Michael Healy AU - Kambiz Malcki AU - Mazhar Chaudri Y1 - 2013/09/01 UR - http://erj.ersjournals.com/content/42/Suppl_57/P5083.abstract N2 - Objectives:To look at the utilisation of EBUS in a UK DGH and evaluate its safety, utility and diagnostic yield.Methods:Data was analysed retrospectively on the first one hundred cases of EBUS guided TBNA. The procedure was done under conscious sedation with use of 2.5-5 mg of Midazolam and 50-100 mcg of Fentanyl alongwith lignocaine throat spray and transtracheal injection. The procedure was done with supplementary oxygen given (range 2-8 L/min, Mean 2.2L, Median 2L) to patients via nasal speculum.Results:100 patients (37% females) underwent the procedure over a period of 2.5 years. Patients’ ages ranged from 32 to 88 (Mean 70, Median 69). Their FEV1 ranged from 0.7 to 3.5 (Mean 1.85, Median 1.82) and their FEV1% ranged from 26% to 121% (Mean 69.5%, Median 71%). The pre-procedure oxygen saturation ranged between 82% to 100% (Mean 95.4, Median 96%). Mininum oxygen saturation during the procedure ranged between 80-100% (Mean 92%, Median 94%). 63 patients (63%) were found to have malignant disease. Diagnostic yield and complication rate were comparable with published data¹. There were no complications or mortality following the procedure.View this table:Conclusion:EBUS-TBNA under conscious sedation in a UK DGH appears to be safe and effective in the diagnosis of mediastinal lymphadenopathy. However, referral for mediastinoscopy is still required for equivocal EBUS guided TBNA samples.Reference:1.EBUS guided TBNA for mediastinal masses. (NICE Feb, 2008). ER -